Hi there! For the coming weeks, our blog will be dedicated to our Young SIOP Award winners!
Please meet Jenneke van Atteveld, YI from The Netherlands, in her own words.
I’m currently working as a clinician-researcher at the Princess Maxima Center for Pediatric Oncology in Utrecht, the Netherlands. My PhD project revolves around bone toxicity and frailty as a result of childhood cancer treatment.
Throughout this PhD trajectory, supervised by Dr. SJCMM Neggers and Prof. dr. MM van den Heuvel-Eibrink and in collaboration with many national and international collaborators, we published consensus recommendations on vitamin D supplementation for children with cancer (Cancer Med 2021), and assessed the effect of post-consolidation regimen on symptomatic osteonecrosis in Dutch ALL protocols (Haematologica 2021).
For childhood cancer survivors, we made a validated prediction model for low bone mineral density (BMD) in collaboration with St. Jude Children’s Research Hospital (J Clin Oncol 2019), assessed the risk and risk factors for (pre)frailty, sarcopenia, (vertebral) fractures and low BMD in a large national cohort (in progress), and developed an IGHG guideline for BMD surveillance (Lancet Diabetes Endocrinol 2021).
Our internationally harmonized guideline for BMD surveillance in childhood, adolescent, and young adult cancer survivors will improve the implementation of and adherence to BMD surveillance recommendations, which facilitates early diagnosis, adequate follow-up and treatment of survivors with low BMD or fractures. This guideline is an important step towards improving bone strength and preventing fractures in this vulnerable group.
We are honored that the SIOP scientific board has rewarded this study with a SIOP Young Investigator Award 2021.
Comments
Post a Comment